Name:	O
___.	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Fatigue,	O
hypoxia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Bilateral	O
Chest	O
tube	O
placement	O
and	O
removal	O
History	O
of	O
Present	O
Illness:	O
In	O
brief,	O
this	O
is	O
a	O
___	O
yo	O
F	O
with	O
squamous	O
cell	O
cancer	O
of	O
neck	O
and	O
lung	O
s/p	O
resection	O
of	O
both	O
with	O
isolated	O
brain	O
metastasis	O
s/p	O
cyberknife	O
who	O
presented	O
with	O
fatigue	O
and	O
hypoxia.	O
She	O
had	O
been	O
having	O
weeks	O
of	O
increasing	O
fatigue,	O
cryptogenic	O
falls	B-Falls
from	O
bed,	O
and	O
overall	O
malaise.	O
Patient	O
denies	O
CP,	O
SOB,	O
palpitations,	O
cough,	O
N/V/D,	O
or	O
dysuria.	O
Imaging	O
remarkable	O
for	O
bilateral	O
pleural	O
effusions	O
and	O
increased	O
mediastinal	O
lymphadenopathy	O
concerning	O
for	O
metastasis.	O
Her	O
labs	O
were	O
notable	O
for	O
lactate	O
of	O
3.8,	O
transaminitis,	O
and	O
anemia.	O
Past	O
Medical	O
History:	O
PMHx:	O
Squamous	O
cell	O
carcinoma	O
___	O
carotid	O
U/S	O
for	O
surveillance	O
of	O
PVD	O
-->	O
incidental	O
1x3cm	O
mass	O
___	O
thyroid	O
U/S	O
showed	O
concerning	O
lymphadenopathy	O
___	O
FNA	O
of	O
L	O
cervical	O
LN	O
-->	O
___	O
___	O
CT	O
chest	O
for	O
scanning	O
-->	O
spiculated	O
8mm	O
nodule	O
L	O
apex	O
and	O
two	O
prominent	O
paratracheal	O
mediastinal	O
LNs	O
___	O
PET	O
scan	O
-->	O
FDG	O
avidity	O
of	O
the	O
L	O
apical	O
nodule	O
and	O
cervical	O
LN,	O
as	O
well	O
as	O
R	O
parotid,	O
R	O
breast,	O
and	O
R	O
axillary	O
LN	O
(subsequent	O
mammogram	O
and	O
U/S	O
reassuring)	O
___	O
MRI	O
brain	O
-->	O
solitary	O
6	O
mm	O
ring	O
enhancing	O
lesion	O
R	O
cerebellar	O
hemisphere	O
suspicious	O
for	O
solitary	O
met	O
___	O
CT	O
neck	O
-->	O
R	O
parotid	O
gland	O
abnormality	O
___	O
tonsillectomy	O
and	O
R	O
parotid	O
exam	O
under	O
anesthesia	O
-->	O
no	O
tumor	O
found	O
in	O
path	O
or	O
on	O
exam	O
___	O
cyber	O
knife	O
to	O
brain	O
lesion	O
___	O
lung	O
nodule	O
resection	O
-->	O
___	O
but	O
unable	O
to	O
determine	O
if	O
the	O
same	O
or	O
different	O
cancer	O
as	O
the	O
L	O
cervical	O
LN	O
___	O
repeat	O
PET	O
-->	O
no	O
further	O
sites	O
of	O
disease	O
than	O
L	O
neck	O
___	O
Heme/Onc	O
(Dr.	O
___	O
--	O
"My	O
opinion	O
is	O
that	O
she	O
had	O
an	O
early	O
lung	O
cancer	O
and	O
an	O
occult	O
head	O
and	O
neck	O
cancer"	O
and	O
recommends	O
neck	O
dissection	O
for	O
definitive	O
tx	O
of	O
L	O
neck	O
___	O
neck	O
dissection	O
done	O
by	O
ENT	O
DM2	O
HTN,	O
HL	O
PVD	O
--	O
s/p	O
L	O
SFA	O
stent,	O
1970s	O
at	O
___	O
H/o	O
smoking	O
Depression	O
Radiculopathy	O
Iron	O
deficiency	O
anemia	O
Intestinal	O
metaplasia	O
Retinal	O
abnormality	O
(___	O
plaque)	O
H/o	O
endometriosis	O
H/o	O
pancreatic	O
cyst	O
PSHx:	O
Tonsillectomy	O
___	O
TAH	O
Peripheral	O
vascular	O
stent	O
placement	O
Cataracts	O
Social	O
History:	O
___	O
Family	O
History:	O
She	O
reports	O
that	O
her	O
mom	O
did	O
not	O
have	O
long	O
or	O
throat	O
cancer	O
as	O
reported	O
in	O
other	O
notes.	O
Her	O
father	O
died	O
of	O
a	O
stroke.	O
A	O
sister	O
had	O
breast	O
cancer.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
General:	O
NAD	O
VITAL	O
SIGNS:	O
T	O
98.3	O
HR	O
96	O
RR	O
20	O
BP	O
140/70	O
O2	O
94%	O
2L	O
(83%	O
RA	O
in	O
the	O
ED)	O
HEENT:	O
MMM,	O
no	O
OP	O
lesions	O
CV:	O
RR,	O
NL	O
S1S2	O
PULM:	O
Decreased	O
breath	O
sounds	O
bilaterally.	O
ABD:	O
Soft,	O
NTND,	O
no	O
masses	O
or	O
hepatosplenomegaly	O
LIMBS:	O
Trace	O
bilateral	O
lower	O
extremity	O
pitting	O
edema	O
R	O
slighly	O
greater	O
than	O
L.	O
SKIN:	O
No	O
rashes	O
or	O
skin	O
breakdown	O
NEURO:	O
Alert	O
and	O
oriented,	B-Delirium
no	O
focal	O
deficits.	O
Discharge	O
Physical	O
Exam:	O
VS:	O
98.6	O
(Tc	O
and	O
Tm),	O
124/74	O
93	O
18	O
93	O
ra.	O
No	O
bm	O
since	O
yesterday.	O
GEN:	O
NAD,	O
sitting	O
up	O
in	O
bed	O
HEENT:	O
Normalocephalic/atraumatic	O
Cards:	O
normal	O
S1/S2,	O
no	O
m/r/g	O
Pulm:	O
Slight	O
crackles	O
at	O
bases,	O
less	O
rhonchi	O
bilaterally	O
Abd:	O
BS+,	O
soft,	O
NT,	O
no	O
rebound/guarding,	O
no	O
HSM,	O
no	O
___	O
sign	O
Extremities:	O
wwp,	O
no	O
edema.	O
Skin:	O
no	O
rashes	O
or	O
bruising	O
Neuro:	O
Alert	O
and	O
conversing	O
well.	O
Moving	O
all	O
extremities.	O
No	O
asterixis	O
on	O
exam.	O
Pertinent	O
Results:	O
Admission	O
Labs	O
___	O
08:13PM	O
LACTATE-3.8*	O
___	O
08:08PM	O
GLUCOSE-98	O
UREA	O
N-25*	O
CREAT-0.7	O
SODIUM-133	O
POTASSIUM-3.5	O
CHLORIDE-91*	O
TOTAL	O
CO2-27	O
ANION	O
GAP-19	O
___	O
08:08PM	O
LD(LDH)-475*	O
___	O
08:08PM	O
proBNP-6108*	O
___	O
08:08PM	O
CALCIUM-9.1	O
PHOSPHATE-3.4	O
MAGNESIUM-2.1	O
IRON-12*	O
___	O
08:08PM	O
D-DIMER-2831*	O
___	O
08:08PM	O
calTIBC-406	O
FERRITIN-31	O
TRF-312	O
___	O
08:08PM	O
WBC-7.3	O
RBC-3.11*	O
HGB-6.0*#	O
HCT-21.5*#	O
MCV-69*#	O
MCH-19.3*#	O
MCHC-27.9*	O
RDW-19.6*	O
RDWSD-47.2*	O
___	O
08:08PM	O
PLT	O
COUNT-418*	O
___	O
08:08PM	O
___	O
PTT-29.9	O
___	O
___	O
08:08PM	O
RET	O
AUT-2.1*	O
ABS	O
RET-0.07	O
Imaging:	O
___	O
CXR	O
IMPRESSION:	O
Small	O
pleural	O
effusions	O
and	O
mild	O
edema.	O
___	O
CTA	O
IMPRESSION:	O
1.	O
No	O
evidence	O
of	O
pulmonary	O
embolism	O
or	O
aortic	O
abnormality.	O
2.	O
Moderate	O
bilateral	O
nonhemorrhagic	O
pleural	O
effusions	O
and	O
pulmonary	O
edema.	O
3.	O
Increase	O
size	O
of	O
mediastinal	O
and	O
right	O
hilar	O
lymphadenopathy	O
suspicious	O
for	O
metastatic	O
disease.	O
4.	O
Small	O
amount	O
of	O
ascites.	O
___	O
TTE	O
The	O
left	O
atrium	O
is	O
normal	O
in	O
size.	O
Left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal.	O
The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal.	O
There	O
is	O
moderate	O
to	O
severe	O
global	O
left	O
ventricular	O
hypokinesis	O
with	O
regional	O
variation	O
(LVEF	O
=	O
30	O
%).	O
Tissue	O
Doppler	O
imaging	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP>18mmHg).	O
Doppler	O
parameters	O
are	O
most	O
consistent	O
with	O
Grade	O
III/IV	O
(severe)	O
left	O
ventricular	O
diastolic	O
dysfunction.	O
The	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied.	O
Right	O
ventricular	O
chamber	O
size	O
is	O
normal.	O
with	O
moderate	O
global	O
free	O
wall	O
hypokinesis.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
number	O
of	O
aortic	O
valve	O
leaflets	O
cannot	O
be	O
determined.	O
The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
(?#).	O
There	O
is	O
a	O
minimally	O
increased	O
gradient	O
consistent	O
with	O
minimal	O
aortic	O
valve	O
stenosis.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Mild	O
(1+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
a	O
restrictive	O
filling	O
abnormality,	O
with	O
elevated	O
left	O
atrial	O
pressure.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
moderately	O
thickened.	O
The	O
supporting	O
structures	O
of	O
the	O
tricuspid	O
valve	O
are	O
thickened/fibrotic.	O
Moderate	O
[2+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
a	O
trivial/physiologic	O
pericardial	O
effusion.	O
There	O
are	O
no	O
echocardiographic	O
signs	O
of	O
tamponade.	O
IMPRESSION:	O
restrictive	O
cardiomyopathy	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
marked	O
deterioration	O
of	O
left	O
and	O
right	O
ventricular	O
function	O
has	O
occurred.	O
___	O
Liver/gallbladder	O
US	O
IMPRESSION:	O
1.	O
Normal	O
appearing	O
liver	O
without	O
evidence	O
of	O
congestion	O
or	O
metastases.	O
2.	O
Gallstones.	O
___	O
IMPRESSION:	O
1.	O
Please	O
note	O
the	O
study	O
is	O
substantially	O
degraded	O
by	O
motion,	O
especially	O
on	O
postcontrast	O
imaging.	O
2.	O
Within	O
limits	O
of	O
study,	O
no	O
definite	O
enhancing	O
intracranial	O
metastasis	O
identified.	O
Recommend	O
clinical	O
correlation.	O
If	O
clinically	O
indicated,	O
consider	O
repeat	O
examination	O
when	O
patient	O
can	O
tolerate	O
exam.	O
3.	O
Stable	O
findings	O
of	O
chronic	O
small	O
vessel	O
ischemic	O
disease.	O
RECOMMENDATION(S):	O
Within	O
limits	O
of	O
study,	O
no	O
definite	O
enhancing	O
intracranial	O
metastasis	O
identified.	O
Recommend	O
clinical	O
correlation.	O
If	O
clinically	O
indicated,	O
consider	O
repeat	O
examination	O
when	O
patient	O
can	O
tolerate	O
exam.	O
___	O
Persantine	O
MIBI	O
INTERPRETATION:	O
This	O
___	O
yo	O
woman	O
with	O
h/o	O
new	O
ischemic	O
cardiomyopathy	O
with	O
s/dCHF,	O
HTN,	O
HLD,	O
and	O
IDDM	O
was	O
referred	O
to	O
the	O
lab	O
from	O
the	O
inpatient	O
floor	O
for	O
evaluation.	O
The	O
patient	O
was	O
administered	O
0.142	O
mg/kg/min	O
of	O
Persantine	O
over	O
4	O
minutes.	O
There	O
were	O
no	O
reports	O
of	O
chest,	O
back,	O
neck,	O
or	O
arm	O
discomforts	O
during	O
the	O
study.	O
In	O
the	O
setting	O
of	O
baseline	O
NSSTTWs,	O
there	O
were	O
no	O
significant	O
ST	O
changes	O
noted	O
during	O
infusion	O
or	O
recovery.	O
Rhythm	O
was	O
sinus	O
with	O
no	O
ectopy.	O
There	O
was	O
an	O
appropriate	O
heart	O
rate	O
and	O
blood	O
pressure	O
response	O
to	O
the	O
infusion.	O
Post-MIBI,	O
the	O
Persantine	O
was	O
reversed	O
with	O
125	O
mg	O
Aminophylline	O
IV.	O
IMPRESSION:	O
No	O
anginal	O
type	O
symptoms	O
or	O
ischemic	O
EKG	O
changes.	O
Nuclear	O
report	O
sent	O
separately.	O
IMPRESSION:	O
Fixed	O
perfusion	O
defect	O
of	O
the	O
inferior	O
wall.	O
Globally	O
reduced	O
wall	O
motion	O
both	O
at	O
rest	O
and	O
stress.	O
These	O
findings	O
are	O
both	O
new	O
compared	O
to	O
prior	O
study,	O
which	O
was	O
normal.	O
Micro:	O
none	O
Pathology:	O
___:	O
cytology	O
negative	O
for	O
malignant	O
Discharge	O
Labs	O
___	O
08:14AM	O
BLOOD	O
WBC-6.5	O
RBC-3.99	O
Hgb-9.0*	O
Hct-31.7*	O
MCV-79*	O
MCH-22.6*	O
MCHC-28.4*	O
RDW-25.7*	O
RDWSD-68.9*	O
Plt	O
___	O
___	O
08:15AM	O
BLOOD	O
___	O
PTT-35.8	O
___	O
___	O
08:14AM	O
BLOOD	O
Glucose-63*	O
UreaN-12	O
Creat-0.6	O
Na-137	O
K-4.6	O
Cl-102	O
HCO3-27	O
AnGap-13	O
___	O
08:14AM	O
BLOOD	O
ALT-39	O
AST-29	O
AlkPhos-163*	O
TotBili-0.6	O
___	O
08:14AM	O
BLOOD	O
Calcium-9.0	O
Phos-4.0	O
Mg-2.0	O
Brief	O
Hospital	O
Course:	O
In	O
brief,	O
this	O
is	O
a	O
___	O
yo	O
F	O
with	O
squamous	O
cell	O
cancer	O
of	O
neck	O
and	O
lung	O
s/p	O
resection	O
of	O
both	O
with	O
isolated	O
brain	O
metastasis	O
s/p	O
cyberknife	O
who	O
presented	O
with	O
fatigue	O
and	O
hypoxia.	O
Imaging	O
remarkable	O
for	O
bilateral	O
pleural	O
effusions	O
and	O
increased	O
mediastinal	O
lymphadenopathy.	O
A	O
diagnosis	O
acute	O
onset	O
CHF	O
with	O
new	O
reduced	O
EF	O
of	O
30%	O
was	O
made.	O
#	O
Hypoxia:	O
Secondary	O
to	O
pulmonary	O
edema	O
and	O
pleural	O
effusions	O
which	O
seem	O
to	O
be	O
related	O
to	O
CHF	O
based	O
on	O
EF	O
and	O
transudative	O
nature	O
of	O
the	O
pleural	O
effusions.	O
No	O
e/o	O
pneumonia	B-Lower_respiratory_tract_infection
or	O
PE	O
based	O
on	O
negative	O
CTA.	O
-Diuresed	O
to	O
euvolemia	O
-s/p	O
bilateral	O
Chest	O
tube	O
placement	O
and	O
removal	O
-Pleural	O
fluid	O
cytology	O
negative	O
for	O
malignancy,	O
cultures	O
NGTD	O
-Wean	O
O2	O
as	O
tolerated:	O
patient	O
asymptomatic	O
but	O
occasionally	O
desatted	O
to	O
the	O
high	O
80's	O
when	O
walking	O
on	O
room	O
air.	O
#	O
Systolic	O
CHF	O
secondary	O
to	O
cardiomyopathy:	O
Patient	O
with	O
worsening	O
CHF	O
based	O
on	O
TTE	O
with	O
EF	O
of	O
30%.	O
Had	O
known	O
NSTEMI	O
related	O
to	O
recent	O
surgical	O
resection	O
with	O
known	O
history	O
of	O
PVD	O
s/p	O
left	O
SFA	O
intervention	O
and	O
risk	O
factors	O
including	O
smoking	O
history,	O
HTN,	O
HLD	O
and	O
diabetes.	O
Per	O
cards,	O
likely	O
a	O
cardiomyopathy	O
that	O
will	O
need	O
further	O
work-up.	O
Persantine	O
mibi	O
showed	O
a	O
fixed	O
wall	O
motion	O
abnormality	O
as	O
well	O
as	O
abnormalities	O
worsening	O
with	O
stress.	O
-Metoprolol	O
XL	O
50	O
-Lisinopril	O
5	O
mg	O
-Ensure	O
dry	O
weight	O
of	O
~120	O
lbs,	O
-Continue	O
atorvastatin	O
-Continue	O
aspirin	O
and	O
Plavix	O
-D/C'd	O
cilostazol	O
for	O
concerns	O
of	O
CHF	O
exacerbation	O
-Outpatient	O
followup	O
#	O
Anemia:	O
Hgb	O
to	O
6.0	O
on	O
presentation;	O
transfused	O
2u	O
pRBC.	O
Has	O
history	O
of	O
iron	O
deficiency	O
anemia	O
with	O
negative	O
colonoscopy/EGD/capsule	O
study	O
in	O
___.	O
No	O
s/sx	O
of	O
bleeding.	O
No	O
e/o	O
hemolysis	O
Iron	O
studies	O
consistent	O
with	O
iron	O
deficiency	O
with	O
low	O
iron/TIBC	O
ratio	O
(<10%).	O
-Started	O
ferrous	O
sulfate	O
325mg	O
daily,	O
uptitrate	O
as	O
tolerated	O
#	O
Transaminitis:	O
Patient	O
has	O
elevated	O
ALT/AST/ALP	O
with	O
increased	O
DBili.	O
RUQ	O
ultrasound	O
without	O
abnormalities.	O
Given	O
downtrending	O
with	O
drainage	O
of	O
effusions	O
and	O
diuresis,	O
suspect	O
this	O
is	O
secondary	O
to	O
hepatic	O
congestion,	O
now	O
improving	O
with	O
euvolemia.	O
-Treatment	O
of	O
CHF	O
as	O
above	O
#Tremor/Asterixis:	O
Suggestive	O
of	O
toxic-metabolic	O
encephalopathy.	B-Delirium
Patient	O
has	O
noticed	O
some	O
tremor	O
when	O
holding	O
her	O
food	O
menu,	O
no	O
issue	O
with	O
tremor	O
when	O
holding	O
fork	O
or	O
eating.	O
CN	O
II-XII	O
intact,	O
minimal	O
dysmetria.	O
Not	O
clear	O
association	O
with	O
rest	O
or	O
intention.	O
Does	O
have	O
asterixis	O
without	O
evidence	O
of	O
overt	O
liver	O
or	O
kidney	O
disease.	O
Appears	O
to	O
be	O
improving	O
-Ammonia,	O
TSH	O
WNL.	O
LFTs	O
improving.	O
-MRI	O
head	O
w/wo	O
contrast;	O
no	O
evidence	O
of	O
new	O
metastasis	O
#	O
Squamous	O
Cell	O
Carcinoma:	O
S/p	O
resection	O
with	O
good	O
margins	O
on	O
lung	O
tumor	O
however	O
with	O
positive	O
lymph	O
node	O
in	O
neck.	O
Found	O
on	O
CTA	O
to	O
have	O
enlarging	O
mediastinal	O
and	O
right	O
hilar	O
lymphadenopathy	O
concerning	O
for	O
metastatic	O
disease	O
-	O
Lymphadenopathy	O
thought	O
to	O
be	O
___	O
to	O
CHF.	O
Dr.	O
___.	O
___.	O
Plan	O
for	O
follow	O
up	O
post-discharge	O
-	O
Pleural	O
fluid	O
cytology	O
negative	O
for	O
malignant	O
cells	O
#	O
Depression:	O
-	O
Continue	O
home	O
citalopram	O
and	O
clonazepam.	O
#	O
DM:	O
glargine	O
dose	O
was	O
decreased	O
due	O
to	O
episodes	O
of	O
hypoglycemia	O
in	O
the	O
am	O
to	O
the	O
low	O
60's.	O
TRANSITIONAL	O
ISSUES	O
[	O
]	O
Cardiology	O
followup	O
scheduled	O
[	O
]	O
Repeat	O
CT	O
chest	O
for	O
mediastinal	O
lymphadenopathy	O
with	O
either	O
Dr.	O
___	O
Dr.	O
___	O
[	O
]	O
Re-assess	O
need	O
for	O
dual	O
anti-platelet	O
therapy	O
[	O
]	O
may	O
uptitrate	O
lisinopril	O
if	O
blood	O
pressure	O
allows	O
[	O
]	O
glargine	O
dose	O
was	O
reduced	O
due	O
to	O
morning	O
hypoglycemia	O
to	O
the	O
low	O
60's	O
(once	O
in	O
the	O
______	O
with	O
poor	O
po	O
intake).	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
wheezing,	O
shortness	O
of	O
breath	O
2.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
3.	O
Citalopram	O
40	O
mg	O
PO	O
DAILY	O
4.	O
ClonazePAM	O
0.5	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
5.	O
Gabapentin	O
300	O
mg	O
PO	O
TID	O
6.	O
Cilostazol	O
100	O
mg	O
PO	O
BID	O
7.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
8.	O
TraMADOL	O
(Ultram)	O
50	O
mg	O
PO	O
Q6H:PRN	O
pain	O
9.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
10.	O
Metoprolol	O
Tartrate	O
12.5	O
mg	O
PO	O
BID	O
11.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
12.	O
Glargine	O
48	O
Units	O
Breakfast	O
13.	O
Clotrimazole	O
Cream	O
1	O
Appl	O
TP	O
BID	O
14.	O
ammonium	O
lactate	O
12	O
%	O
topical	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Albuterol	O
Inhaler	O
2	O
PUFF	O
IH	O
Q4H:PRN	O
wheezing,	O
shortness	O
of	O
breath	O
2.	O
Aspirin	O
325	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
4.	O
Citalopram	O
40	O
mg	O
PO	O
DAILY	O
5.	O
ClonazePAM	O
0.5	O
mg	O
PO	O
QHS:PRN	O
insomnia	O
RX	O
*clonazepam	O
0.5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
at	O
bedtime	O
Disp	O
#*4	O
Tablet	O
Refills:*0	O
6.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
7.	O
Clotrimazole	O
Cream	O
1	O
Appl	O
TP	O
BID	O
8.	O
Gabapentin	O
300	O
mg	O
PO	O
TID	O
9.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
DAILY	O
10.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
11.	O
ammonium	O
lactate	O
12	O
%	O
topical	O
DAILY	O
12.	O
MetFORMIN	O
(Glucophage)	O
1000	O
mg	O
PO	O
BID	O
13.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
14.	O
Glargine	O
17	O
Units	O
Breakfast	O
Insulin	O
SC	O
Sliding	O
Scale	O
using	O
REG	O
Insulin	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Heart	O
Failure	O
reduced	O
Ejection	O
Fraction	O
30%	O
secondary	O
to	O
cardiomyopathy	O
c/b	O
bilateral	O
pleural	O
effusions	O
and	O
hypoxia	O
Squamous	O
Cell	O
Carcinoma	O
of	O
neck	O
and	O
lung	O
Transaminitis	O
secondary	O
to	O
hepatic	O
congestion	O
Toxic	O
Metabolic	O
Encephalopathy	B-Delirium
Anemia	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
for	O
weeks	O
of	O
fatigue	O
which	O
led	O
to	O
a	O
finding	O
of	O
a	O
low	O
oxygen	O
level	O
in	O
the	O
emergency	O
department.	O
It	O
was	O
discovered	O
that	O
your	O
heart	O
was	O
not	O
pumping	O
as	O
well	O
and	O
fluid	O
had	O
backed	O
up	O
into	O
your	O
lungs.	O
We	O
helped	O
take	O
off	O
this	O
fluid	O
with	O
medication	O
as	O
well	O
as	O
two	O
chest	O
tubes.	O
The	O
cause	O
of	O
your	O
fatigue	O
and	O
low	O
oxygen	O
was	O
thought	O
to	O
be	O
due	O
to	O
a	O
new	O
reduction	O
in	O
the	O
pump	O
function	O
of	O
your	O
heart.	O
Further	O
testing	O
did	O
not	O
reveal	O
an	O
area	O
to	O
intervene	O
on	O
with	O
a	O
procedure.	O
We	O
will	O
treat	O
this	O
with	O
medications	O
and	O
suggest	O
follow-up	O
with	O
an	O
outpatient	O
cardiologist.	O
Please	O
take	O
all	O
your	O
medications	O
as	O
prescribed	O
and	O
attend	O
all	O
your	O
follow-up	O
appointments.	O
It	O
was	O
a	O
pleasure	O
to	O
take	O
care	O
of	O
you	O
here	O
at	O
___.	O
Please	O
weigh	O
yourself	O
daily	O
and	O
if	O
you	O
gain	O
3	O
lbs	O
or	O
more,	O
please	O
call	O
your	O
doctor.	O
Sincerely,	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

